We are live on ! Find out more
IHAM

Integral Health Asset Management Portfolio holdings

AUM $2.09B
1-Year Est. Return 112.84%
This Fund
S&P 500
This Quarter Est. Return
+13.31%
1 Year Est. Return
+112.84%
3 Year Est. Return
+485.32%
5 Year Est. Return
+783.01%
10 Year Est. Return
–
AUM
$327M
AUM Growth
-$6.98M
Cap. Flow
-$27.2M
Cap. Flow %
-8.32%
Top 10 Hldgs %
35.72%
Holding
92
New
32
Increased
20
Reduced
19
Closed
20

Top Buys

Rank Stock Value
1
RVTY icon
Revvity
RVTY
+$9.19M
2
SNY icon
Sanofi
SNY
+$6.44M
3
ABT icon
Abbott
ABT
+$6.09M
4
CNC icon
Centene
CNC
+$5.9M
5
EHTH icon
eHealth
EHTH
+$5.67M

Top Sells

Rank Stock Value
1
DGX icon
Quest Diagnostics
DGX
+$13.7M
2
LHCG
LHC Group LLC
LHCG
+$9.87M
3
BMY icon
Bristol-Myers Squibb
BMY
+$9.03M
4
DHR icon
Danaher
DHR
+$7.96M
5
SGEN
Seagen Inc. Common Stock
SGEN
+$7.65M

Sector Composition

Rank Sector Weight
1 Healthcare 85.4%
2 Energy 4.88%
3 Financials 1.69%
4 Consumer Discretionary 0.59%
5 Technology 0.22%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
LHCG
1
DELISTED
LHC Group LLC
LHCG
$15.9M 4.88%
75,000
-50,000
-40% -$9.87M
SAGE
2
DELISTED
Sage Therapeutics
SAGE
$14.1M 4.3%
230,000
+35,000
+18% +$1.77M
RVTY icon
3
Revvity
RVTY
$12.6B
$13.8M 4.22%
110,000
+80,000
+267% +$9.19M
ABT icon
4
Abbott
ABT
$184B
$12M 3.66%
110,000
+60,000
+120% +$6.09M
ARNA
5
DELISTED
Arena Pharmaceuticals Inc
ARNA
$11.2M 3.43%
150,000
-25,000
-14% -$1.67M
HUM icon
6
Humana
HUM
$43.1B
$10.8M 3.29%
26,000
+6,000
+30% +$2.41M
CCXI
7
DELISTED
ChemoCentryx, Inc.
CCXI
$10.1M 3.1%
185,000
+35,000
+23% +$1.88M
BPMC
8
DELISTED
Blueprint Medicines
BPMC
$9.73M 2.98%
105,000
-5,000
-5% -$385K
COR icon
9
Cencora
COR
$61B
$9.69M 2.96%
100,000
+10,000
+11% +$994K
NVRO
10
DELISTED
NEVRO CORP.
NVRO
$9.47M 2.9%
68,000
-7,000
-9% -$935K
MCK icon
11
McKesson
MCK
$98.7B
$9.23M 2.82%
62,000
+37,000
+148% +$5.62M
BMRN icon
12
BioMarin Pharmaceuticals
BMRN
$11.5B
$9.13M 2.79%
120,000
+40,000
+50% +$4.05M
MRK icon
13
Merck
MRK
$318B
$8.29M 2.54%
104,800
+26,200
+33% +$2.05M
CRL icon
14
Charles River Laboratories
CRL
$12.5B
$7.47M 2.29%
33,000
-22,000
-40% -$4.57M
ZBH icon
15
Zimmer Biomet
ZBH
$18.8B
$6.81M 2.08%
51,500
+15,450
+43% +$2.02M
GWPH
16
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
$6.33M 1.94%
65,000
-10,000
-13% -$1.15M
SNY icon
17
Sanofi
SNY
$105B
$6.27M 1.92%
+125,000
New +$6.44M
NVST icon
18
Envista
NVST
$4.63B
$6.17M 1.89%
250,000
+75,000
+43% +$1.73M
DNLI icon
19
Denali Therapeutics
DNLI
$3.9B
$5.91M 1.81%
165,000
+35,000
+27% +$1.05M
CNC icon
20
Centene
CNC
$31.6B
$5.54M 1.69%
+95,000
New +$5.9M
EHTH icon
21
eHealth
EHTH
$41.9M
$5.53M 1.69%
+70,000
New +$5.67M
PODD icon
22
Insulet
PODD
$9.45B
$5.21M 1.59%
22,000
+4,000
+22% +$842K
MRTX
23
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
$4.98M 1.52%
30,000
-20,000
-40% -$2.74M
NTRA icon
24
Natera
NTRA
$38.1B
$4.77M 1.46%
+66,000
New +$3.75M
CYTK icon
25
CALL
Cytokinetics
CYTK
$10.8B
$4.33M 1.32%
+200,000
New +$4.68M
1
2 3 4

Similar funds

CL
CSS LLC Chicago, Illinois $2.09B AUM 58.96% 1-Year Est. Return
ACM
Analog Century Management New York $2.09B AUM 186.85% 1-Year Est. Return
NSCM
New South Capital Management Memphis, Tennessee $2.09B AUM 33.67% 1-Year Est. Return
ACG
Aventail Capital Group New York $2.09B AUM 43.81% 1-Year Est. Return
NSUP
NLB Skladi upravljanje premozenja Ljubljana $2.09B AUM
TP
Third Point New York $2.08B AUM 27.04% 1-Year Est. Return
ACP
Avantyr Capital Partners New York $2.08B AUM
TA
TruWealth Advisors Metairie, Louisiana $2.08B AUM 21.15% 1-Year Est. Return

Integral Health Asset Management's Q3 2020 Portfolio in Review

As of Q3 2020, Integral Health Asset Management held 92 positions worth $327M, down 2.1% from $334M the previous quarter. Its ten largest holdings account for 36% of the portfolio.

Integral Health Asset Management withdrew a net $27.2M in Q3 2020, closing 20 positions and reducing 19 holdings. Its most notable exit was Quest Diagnostics, an estimated $13.7M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 85% of assets, down from 87% a quarter earlier, followed by Energy and Financials.

Against the trend, Integral Health Asset Management opened a new position in Sanofi worth $6.27M.

  • Integral Health Asset Management's largest Q3 2020 buy was Sanofi: 125,000 shares worth $6.27M.
  • Integral Health Asset Management added most to Revvity in Q3 2020, an estimated $9.19M increase.
  • Integral Health Asset Management's biggest Q3 2020 reduction was LHC Group LLC, cutting an estimated $9.87M.
  • Integral Health Asset Management fully exited Quest Diagnostics in Q3 2020, selling an estimated $13.7M.
  • Integral Health Asset Management's ten largest holdings make up 36% of its $327M portfolio in Q3 2020.
  • Integral Health Asset Management opened 32 new positions and closed 20 in Q3 2020.
  • Integral Health Asset Management's portfolio value fell 2.1% quarter-over-quarter to $327M.

Based on Integral Health Asset Management's 13F filing for Q3 2020, filed 16 Nov 2020.